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Evidence for antibody formation by various cells, tissues, and organs has
come mainly from studies employing the following methods: (i) extracts of
tissue cultures,'l (ii) cannulization of afferent and efferent lymph,"'X
(iii) extracts of cells, tissues, and organs,"' (iv) extirpation of the
spleen," and (v) roentgen-radiation of animals with lead-protected
mobilized spleens.' Although the reports arising from these are contro-
versial, there now seems but little doubt that spleen and lymph nodes
actively producing antibody in the intact animal will continue to do so for
a few hours following removal and transfer to tissue culture. There is also
fairly uniform agreement that the addition of antigen to a tissue culture
does not increase, but may prevent, the formation of antibody.
The present study indicates that the anterior chamber of the eye of the
irradiated mouse provides a good site for studying antibody formation by
isolated tissue transplants. A distinct advantage is that the intraocular
transplant is nourished in a more physiological manner than is possible with
tissue culture methods. Tetanus antitoxin production by the transplants was
studied because very small amounts of this antibody can be detected with
good quantitative accuracy. The anamnestic response was employed to test
the capacity of various intraocular transplants to produce this antitoxin.
The advantage of employing this recall response lies in the greatly increased
amount of antitoxin produced by a given quantity of antigen and its much
more rapid production.
MATERIALS AND METHODS
Spleen and lymph node tissue from the donor was removed 30 to 60 days after the
primary or secondary antigenic stimulus, as described in the various experiments. The
tissue fragments, about 1 mm. in diameter, were transplanted into the anterior cham-
bers of mice within one to three hours after irradiation. All recipient mice and irradi-
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ated controls in the experiments reported here received 600 Rep. whole-body cobalt-60
irradiation. This amount of irradiation normally causes no deaths in our four-week-
old mice. The LD5o for mice of this age is 750 Rep. on our source. Irradiation of the
recipient mice served the two-fold purpose of increasing the percentage "take" of the
transplants and of practically abolishing antibody production by the recipient animals,
thus increasing the probability of detecting the amount of antibody produced by the
transplanted tissue. Six to 12 days after the transplants were established, the mice
were injected intravenously with 0.2 ml. of a 1: 4 dilution of fluid toxoid and 9 to 11
days later, they were bled. At this time, the mice with regressing transplants were
discarded. The tetanus toxin* used in these experiments was ammonium sulphate pre-
cipitated and dried. A 2% solution of toxin was made in 50% buffered (pH 7.4)
reagent glycerine and stored in ampoules at -l18 C. If the precaution is taken always
to use a dry syringe for removal, the toxin will remain stable for many months under
these conditions and the original titration can be relied upon. Titration of the toxin
was done in three stages: rough, semi-fine, and fine. Ten mice of our inbred strain
were used for each dilution in the final titration. The antitoxin combining power was
determined by comparing it to a standard obtained from the Institute of Health. The
titration of the antitoxic serum from the various experiments was always done in at
least two stages, a rough and a fine, and sometimes in three stages. This greatly
decreases the number of mice required. We found the inbred strain of mice to be very
uniform in their reactions to tetanus toxin and that two to four mice for each mixture
gave very uniform results. Except for the very low unitage, the serum was varied and
the toxin was held constant. For the very small amounts of antitoxin, it was more
practical to hold the serum constant and vary the amount of toxin. All dilutions of
toxin and serum were made in beef heart infusion broth. The titrations were read at
the end of four days and we found it more accurate to use minimal paralysis instead
of death as an end-point. However, the lethal end-point could be used without making
a significant difference in the results.
EXPERIMENTAL
The first experiment was designed to determine whether tetanus antitoxin
formation by lymph node and spleen intraocular transplants from immune
donors into irradiated recipients could be detected. The donor mice had
received one injection of 0.05 ml. alum-precipitated tetanus toxoid 30 days
prior to the removal of the tissue for transplantation. These animals had
from 0.125 to 0.250 International units of tetanus antitoxin at the time the
tissues were taken for transplantation. The experiment was designed to test
the formation of antitoxin by the transplant without further antigenic stimu-
lation, as well as the effect of a secondary stimulus consisting of 0.2 ml. of
a 1: 4 dilution of fluid tetanus toxoid injected intravenously into the tail
vein of the recipient irradiated mice 10 days following transplantation.
* We are indebted to Lederle Laboratories, Pearl River, New York, for a generous
supply of this toxin.
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From Table 1, it is clear that lymph node tissue which was given a
secondary stimulus responded by producing tetanus antitoxin, whereas
lymph node transplants not so stimulated did not produce detectable quan-
tities. The spleen tissue possibly produced a very small amount after stimu-
lation, and none without stimulation. Frontal sections through the anterior
chamber of the eye, containing lymph node and spleen transplants, are
shown in Figure 1 and Figure 2 respectively. These sections were taken
seven weeks from the time of transplantation.
TABLE 1: TETANUS ANTITOXIN PRODUCTION BY LYMPH NODE AND SPLEEN
TRANSPLANTS IN ANTERIOR CHAMBERS OF EYES OF IRRADIATED MICE
Spleen and lymph node donor tissues were taken from mice that had received
only one injection of alum-precipitated tetanius toxoid subcutaneously
30 days prior to the transplantation
20 mitice in each Toxoid treatment Fraction of No. of AILD of
series received 10 days after Inttern. unit tetant(s toxin
in a.c. of receiving transplants mnl. of pooled neutralized by
each eye to a.c. of eyes serumt fromt grouip 1 mnl. of pooled serumii
I-spleen Not inj. < .00004 < 1.5
II-spleen Fluid tetanus .00007 2.0
toxoid i.v.
III-lymph node Not inj. < .00004 < 1.5
IV-lymph node Fluid tetanus .01 400.0
toxoid i.v.
Because of the marked destructive action of the gamma irradiation on
the lymph nodes and spleen of the recipient mice, the second experiment
was designed to confirm the first one and also to test the possibility that
spleen transplanted to one eye and lymph node transplanted to the other
eye might have a stimulating or synergistic effect on each other. No increase
in antitoxin formation resulted from a combination of lymph node and
spleen transplants (Table 2). These mice had less antitoxin than those in
Group II which had lymph node in the anterior chamber of each eye. It is
also clear that the transplant must receive a secondary stimulus in order to
produce a detectable amount of tetanus antitoxin. The amount of antitoxin
produced by the mice in Group II is only 0.1 as much as in a similar group,
Group IV in Table 1. The cause of this variation is not yet determined.
The very doubtful formation of tetanus antitoxin by the spleen trans-
plants was somewhat surprising in view of the very definite production by
48
Volume 26,September 1953FIG. 1. Frontal section of lymph node transplant in anterior chamber of the eye




FIG. 2. Frontal section of spleen transplant in anterior chamber of the eye seven
weeks after transplantation. Stained with hematoxylin and eosin.Tetanus antitoxin from intraocular transplants IHALE, STONER
the lymph node transplants. It should be emphasized here that in the first
experiments the donor mice received only one subcutaneous immunizing
injection of alum-precipitated tetanus toxoid. Under this condition, lymph
node tissue definitely produced antitoxin, whereas antibody formation by
splenic tissue was doubtful. The possibility that spleen from donors having
had both a primary and secondary stimulus might be better for transplants
ofthis tissue was tested in the third experiment. The donor mice were given
TABLE 2: TETANUS ANTITOXIN PRODUCTION FOLLOWING COMBINED LYMPH NODE
AND SPLEEN TRANSPLANTS FROM IMMUNE MICE TO IRRADIATED MICE
Donor mice were immunized by a single subcutaneous injection of 0.05 ml. of
alum-precipitated tetanus toxoid 55 days prior to transplantation
Toxoid treatment Fraction of No. of MLD of
No. of mice 9 days after Intern. unitl tetanus toxin
receiving receiving transplants ml. of pooled neutralized by
transplants to a.c. of eyes serum from group 1 ml. of pooled serum
I-20, no transplant Fluid tetanus < .00004 < 1.5
Irradiated controls toxoid i.v.
II-25, lymph node* " " .001 40.0
III-25, spleen* " " < .00004 < 1.5
IV-25, lymph node in " " .0003 12.0
a.c. of one eye and
spleen in a.c. of
other eye
V-25, lymph node* Not inj. < .00004 < 1.5
* In a.c. of each eye.
0.05 ml. alum-precipitated tetanus toxoid subcutaneously for the primary
stimulus and 0.05 ml. of fluid toxoid intra-abdominally 22 days later for the
secondary stimulus. The splenic tissue was removed for transplantation six
days following the second injection. The donor mice having received two
such injections had from 7.5 to 20 International units of tetanus antitoxin
per ml. of serum 10 days after the second injection. Because of the antitoxin
content of the donors' tissue, it was desirable to have a control on the
amount of antitoxin carried over by the tissue transplants. For this pur-
pose, twice-frozen and thawed splenic tissues from the immune donors
were transplanted to the mice in Group III, Table 3. The recipient animals
in Groups I and III were given 0.05 ml. fluid tetanus toxoid intravenously
12 days after receiving the transplants. Those in Group II were not injected
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with toxoid, serving as controls for the amount of antitoxin formed by the
live spleen transplants over a period of 12 days without further antigenic
stimulus. Under the conditions of this experiment there is no doubt that the
spleen transplants from twice-stimulated donors can form antitoxin in the
irradiated recipients without any further antigenic stimulus if the donor tis-
sue is taken during the active phase of antitoxin production. However, the
intravenous injection of toxoid into the recipients more than doubled the
amount of antitoxin produced. The antitoxin content of the serum from the
TABLE 3. PRODUCTION OF ANTITOXIN BY SPLEEN TRANSPLANTS FROM DONORS
RECEIVING ALUM-PRECIPITATED TOXOID SUBCUTANEOUSLY FOR 1ST INJECTION
AND FLUID TOXOID INTRA-ABDOMINALLY FOR THE 2D STIMULUS 22 DAYS LATER.
Twice-frozen and thawed spleen from similar donors was used as control.
Donor tissue was taken 6 days after 2d injection
No. of Toxoid treatment Fraction of No. of MLD of
mice receiving 12 days after Intern. unit/ tetanus toxin
in a.c. of receiving transplants ml. of pooled neutralized by
each eye to a.c. of eyes serum from group 1 ml. of pooled serum
I-25, fresh Fluid tetanus .00125 50.0
spleen transplants toxoid i.v.
II-25, fresh Not inj. .00047 19.0
spleen transplants
III-25, frozen and Fluid tetanus .00004 1.5
thawed spleen toxoid i.v.
transplants
mice in Group III indicates that only a very small amount of antitoxin is
passively introduced by the frozen and thawed transplant.
Whole-body irradiation of the donor mice will greatly reduce the per-
centage and duration of "takes" of spleen transplants in irradiated recipient
mice. Therefore, to control better this carry-over of antitoxin by donor
tissue, an experiment was designed to use spleens from twice-stimulated,
irradiated donors. The irradiated donors were given 600 Rep. cobalt-60y
whole-body irradiation one to three hours before the tissues were removed
for transplantation. Spleens were taken from the immune donors 12 days
after the secondary stimulus. The results of this experiment are represented
in Table 4.
As can be seen, the serum from the mice in Group I and Group II-the
recipients of the immune spleen from irradiated donors-had a just detect-
able amount of antitoxin. The injection of toxoid intravenously did not
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increase the amount of antitoxin. The animals in Group I have no more
antitoxin than those in Group II. In contrast to this, the mice in Group III
with spleen transplants from non-irradiated immune donors and which had
been given toxoid intravenously seven days after receiving the transplant
had 0.001 International units of antitoxin per ml. of serum. The antitoxin
content of the serum from the animals in Group IV is greater than in the
control Groups I and II. Although this difference is not great, it exceeds
the experimental error in titration, indicating that the spleen from non-
TABLE 4. COMPARISON OF ANTITOXIN-FORMING ABILITY OF SPLEEN TRANSPLANTS
FROM IRRADIATED, ANTIGENICALLY TWICE-STIMULATED DONORS TO SPLEEN
TRANSPLANTS FROM SIMILARLY IMMUNIZED, BUT NON-IRRADIATED DONORS
No. of Toxoid treatment Fraction of No. of MLD of
mice receiving 7 days after Intern. unit/ tetanus toxin
spleen in receiving transplants ml. of pooled neutralized by
each eye to a.c. of eyes serum from group 1 ml. of pooled serum
I-19, from Fluid tetanus .00004 1.5
irradiated toxoid i.v.
donors
II-18, from Not inj. .00004 1.5
irradiated
donors
III-21, from Fluid tetanus .001 50.0
non-irradiated toxoid i.v.
donors
IV-21, from Not inj. .0001 4.5
non-irradiated
donors
irradiated donors, without further stimulation, and after having been trans-
planted to an irradiated host, continued to produce a small amount of
antitoxin.
It may be well to point out that the splenic tissues were removed from
the immune donors in this experiment 12 days after the secondary stimulus,
whereas they were removed six days after such treatment in the experiment
illustrated in Table 3. The more active antitoxin formation on the sixth day
as compared to the twelfth day may explain the difference between the com-
parable Group II, Table 3, and Group IV, Table 4.
When donor mice immunized by a single subcutaneous injection of alum-
precipitated tetanus toxoid were used in the first two experiments reported
here, there was a clear-cut difference between the production by the lymph
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node and spleen intraocular transplants. The results with lymph node were
conclusive. The formation of antitoxin by splenic tissue under these condi-
tions was doubtful. However, when this was used from donors that had
received 2 immunizing injections, there was no doubt that these trans-
plants could form antibody after being transplanted into the eyes of irradi-
ated mice. Therefore, it was desirable to compare twice-stimulated lymph
TABLE 5: PRODUCTION OF TETANUS ANTITOXIN BY LYMPH NODE AND SPLEEN
TRANSPLANTS FROM DONOR MICE THAT RECEIVED ALUM-PRECIPITATED TOXOID
SUBCUTANEOUSLY AND 66 DAYS LATER RECEIVED FLUID TOXOID
INTRA-ABDOMINALLY
Twice-frozen and thawed spleen was used as control on amount of antitoxin
carried over by transplants from the immune donor. The tissues were
transplanted 9 days following second injection of antigen
No. of Toxoid treatment Fraction of No. of MLD of
mice receiving 6 days after Intern. unitl tetanus toxin
in a.c. of receiinng transplants mt. of pooled neutralized by
each eye to a.c. of eyes serum from group 1 ml. of pooled serum
I-24, lymph node Fluid tetanus .004 150.0
toxoid i.v.
II-24, lymph node Not inj. .0009 37.5
III1-24, spleen Fluid tetanus .02 830.0
toxoid i.v.
IV-24, spleen Not inj. .0025 100.0
V-20, no transplant- Fluid tetanus < .00004 < 1.5
Irradiated controls toxoid i.v.
VI-25, frozen and " .00004 1.5
thawed spleen
and spleen tissue for their ability to produce antitoxin. The results of this
experiment are given in Table 5. As can be seen, the amount of antitoxin
produced by both the lymph node and spleen transplants is very much
greater than in any of the previous experiments. This was true where the
transplant was not stimulated as well as wfhere an intravenous injection of
fluid toxoid was given to the recipients 6 days after receiving the trans-
plants. It is quite evident from an examination of this table that an antigenic
stimulus greatly increases the formation of antitoxin by both transplants.
One might conclude from this experiment that spleen was a much better
antitoxin-forming organ than lymph node. We do not believe that such a
conclusion should be made in view of the variable results obtained in the
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different experiments. At present we cannot be sure what the reasons for
this quantitative variation may be, but work in progress may at least par-
tially answer it. Whether or not the lymph nodes used for transplanting are
regional to the site of the first alum-precipitated toxoid injection may be
one of the reasons. Unfortunately, no attention was given to this point in
any of these experiments. We believe that the difference between the red
pulp and the white pulp of the spleen may also account for the varying
amounts of antitoxin produced by the splenic transplants. The recent work
of Thorbecke and Keuning6 would support both of these views.
One should not conclude from these experiments that the spleen is more
difficult to sensitize than the lymph node, because the first sensitizing injec-
tions were always subcutaneous in these experiments. We are now trying
intravenous, as well as intraperitoneal and subcutaneous, sensitization of
the donors, in the latter case comparing the lymph nodes regional to the
site with those remote from the site.
Two experiments have been done with intraocular transplants of thymus
and Peyer's patch tissue from immune mice into irradiated recipients. One
experiment was positive for both tissues and one was negative for both.
One experiment has been done with skin transplants. This tissue grows
better in the anterior chamber than any other we have tried, but no
detectable antitoxin was produced.
The M.L.D. of tetanus toxin and botulinus toxin is the same on a milli-
gram for milligram basis. Because the molecular weight of tetanus toxin is
72,000 and that of botulinus toxin is given as 900,000, we believe that a
much smaller amount of botulinus antitoxin can be detected than can
tetanus antitoxin. We plan to compare the sensitivity of these 2 antigens
for this purpose.
SUMMARY
1. Lymph node and spleen tissue from immunized donor mice will produce
tetanus antitoxin when transplanted to the anterior chamber of the eye of
gamma irradiated recipients.
2. More antitoxin is formed by the transplants from immunized donors
when the recipients are injected intravenously with fluid tetanus toxoid.
REFERENCES
1 Liidke, H.: tber Antikorperbildung in Kulturen lebender K6rperzellen. Ber. klin.
Wschr., 1912, 49, 1034.
2 Meyer, K. and Loewenthal, H.: Untersuchungen ilber Antik6rperbildung in
Gewebekulturen. Zschr. Immunforsch., 1928, 54, 420.
3 Landsteiner, K. and Parker, R. C.: Studies on the production of antibodies in
vitro. Science, 1937, 85, 292.
4 Tsai, L. H.: The production of diphtheric antitoxin in tissue-cultures. J. Immun.,
Balt., 1937, 33, 471.
53YALE JOURNAL OF BIOLOGY AND MEDICINE Volume 26, September 1953
3 Fragraeus, A.: Antibody production in relation to the development of plasma
cells. Acta med. scand., 1948, 130/204, 9-122.
6 Thorbecke, G. J. and Keuning, F. J.: Antibody formation in sitro by haemo-
poietic organs after subcutaneous and intravenous immunization. J. Immun.,
Balt., 1953, 70/2, 129.
7 Salle, A. J. and McOmie, W. A.: Immunological responses of tissues cultivated
in vitro. J. Immun., Balt., 1937, 32, 157.
8 Kuczynski, M. H., Tenenbaum, E., and Werthemann, A.: Untersuchungen uber Ernahrung und Wachstum der Zellen erwachsener Siiugetiere in Plasma unter
Verwendung wohlcharakerisierter Zusatze au Stelle von Gewebsauszugen.
Virchows Arch., 1925, 258, 687.
9 Carrel, A. and Ingebrigsten, R.: The production of antibodies by tissues living
outside of the organism. J. Exp. M., 1912, 15, 287.
10 Schilf, F.: Die Bildung von Bakteriolysinen in kunstlichen Gewebskulturen. Zbe.
Bakt., 1926, 97, 219.
11 Miyazawa.: Die Bedeutung der Endocardzellin bei der Antik6rperbildung in
Gewebekulturen. Tr. Jap. Path. Soc., 1931, 31, 126.
12 Bloom, W.: Immune reactions in tissue culture; reaction of lungs from normal
and immunized rabbits to pigeon erythrocytes. Arch. Path. Lab. Med., 1927,
3, 608.
13 Komatsu, S.: Studien uber bakterizide Stoffe in der Gewebezuchtung. Zschr.
Immunforsch., 1931, 71, 76.
14 Takahashi, S.: Ueber die Antikorperbildung in der Lymphdruse. Arb. Anat. Inst.
Univ. Sendai, 1933, 67.
15 Ehrich, W. E. and Harris, T. N.: The formation of antibodies in the popliteal
lymph nodes in rabbits. J. Exp. M., 1942, 76, 335.
16 Pfeiffer, R.: Die Bildung statte der Choleraschutzstoffe. Zschr. Hyg., 1898, 27,
272.
17 McMaster, P. D. and Hudack, S. S.: The formation of agglutinins within lymph
nodes. J. Exp. M., 1935, 61, 783.
18 McMaster, P. D. and Kidd, J. G.: Lymph node as a source of neutralizing princi-
ple for vaccinia. J. Exp. M., 1937, 66, 73.
19 Oakley, C. L., Warrack, G. H., and Batty, I.: Sites of antibody formation. J.
Path. Bact., Lond., 1949, 61/2, 179.
20 Mondolfo, H. I.: Lymphocytes and immunity. Gior. batt. immun., 1949, 40/3, 225.
21 Harris, S. and Harris, T. N.: Influenzal antibodies in lymphocytes of rabbits
following the local injection of virus. J. Immun., Balt., 1949, 61/2, 193.
22 Jatta, M.: Experimentalle Untersuchungen uber die Agglutination des Typhus-
bacillus und der Mikroorganismen der Coligruppe. Zschr. Hyg., 1900, 33, 185.
23 DeGara, P. F. and Angevine, D. M.: Studies on the site of antibody formation in
rabbits following intracutaneous injection. J. Exp. M., 1943, 78, 27.
24 Harris, T. N., Rhoads, J., and Stokes, J., Jr.: A study of the r6le of the thymus
and spleen in the formation of antibodies in the rabbit. J. Immun., Balt., 1948,
58/1, 27.
25 Fragraeus, A.: The plasma cellular reaction and its relation to the formation of
antibodies in vitro. J. Immun., Balt., 1948, 58/1, 1.
26 Adams, E., Roberts, S., and White, A. J.: Influence of mode of immunization on
the relationship between the development of tissue titers and the release of
hemolysins in vitro. J. Immun., Balt., 1949, 62, 155.
27 Oakley, C. L., Batty, I., and Warrack, G. H.: Local production of antibodies. J.
Path. Bact., Lond., 1951, 63/1, 33.
28 Habel, K., Endicott, K. M., Bell, J. F., and Spear, F.: Immunological evidence on
the r6le of the lymphocyte in antibody formation. J. Immun., Balt., 1949, 61/2, 131.
29 Hektoen, L.: Further observations on the effects of roentgenization and splenec-
tomy on antibody-production. J. Infect. Dis., 1920, 27, 23.
30 Rowley, D. A.: The effect of splenectomy on the formation of circulating anti-
body in the adult male albino rat. J. Immun., Balt., 1950, 64, 289.
31 Jacobson, L. 0. and Robson, M. J.: Factors effecting x-ray inhibition of antibody
formation. J. Laborat. Clin. M., 1952, 39, 169.
54